University of California, San Francisco (Fresno)
Internal Medicine residency · Fresno, CA · Program website
- 1
- Faculty
- 30
- Trainees
- 55
- Papers
- 23%
- Trainees published
- 26%
- First author
12 people are awaiting a match decision, so numbers may change.
Papers
By this program's faculty and trainees since 2022, 55 in all. Updated 2026-11-06.
- Three years of RCVS and PRES cases at a single comprehensive stroke center: observations on clinical presentation, headache features, triggers, and managementSarah Ahmad et al. · Frontiers in Neurology · 2026
- Chronic cannabis smoking-enriched oral pathobiont drives behavioral changes, macrophage infiltration, and increases β-amyloid protein production in the brainDavide Amato et al. · UNC Libraries · 2026
- Plasma Biomarker Effects of Oral Valiltramiprosate/ALZ-801 in Early Alzheimer’s Disease from Phase 3 and Phase 2 Trials: Analysis of Core Biomarkers and Correlations with Clinical and Neuroimaging OutcomesJohn A. Hey et al. · Drugs · 2026 · PubMed
- The Prevalence and Characteristics of Obstructive Sleep Apnea Among Patients With Multiple Sclerosis: A Systematic Review and Meta-AnalysisAhmad A. Toubasi et al. · Journal of Central Nervous System Disease · 2026 · PubMed
- Air Pollution and the Risk and Progression of Multiple Sclerosis: A Systematic Review and Meta-analysis (P4-19.005)Ahmad A. Toubasi et al. · Neurology · 2026
- Peripheral Immune Markers in Dementia: A Systematic Review and Meta-analysis of Risk, Severity, and Pathological Correlates (P7-12.006)Thuraya N. Al‐Sayegh et al. · Neurology · 2026
- The neurological adverse events of immune check point inhibitors in the treatment of cancerAhmad A. Toubasi et al. · Journal of Neurology · 2026 · PubMed · cited 1
- Neurological adverse events related to immune checkpoint inhibitors in cancer treatment: A systematic review and meta-analysis of clinical trials.Thuraya N. Al‐Sayegh et al. · Journal of Clinical Oncology · 2026
- Head injuries as a risk factor for amyotrophic lateral sclerosis: A systematic review and meta-analysisAhmad A. Toubasi et al. · Clinical Neurology and Neurosurgery · 2026 · PubMed · cited 1
- A53-18 Retch and Rupture: An Unexpected Cause of PneumomediastinumIrma Jarovic et al. · American Journal of Respiratory and Critical Care Medicine · 2026
How trainees publishauthor positions, faculty co-authorship, ranks
Papers by current residents and fellows, and alumni within two years, published during training. Based on 9 of 30 trainees matched to publication records. Trainees with no match count as not yet published, so these figures are a floor.
Faculty detailsh-index, papers and author positions per person
Program leadership from the program's own pages, matched to publications. Leadership is mostly clinician-educators, so these numbers describe the teaching team, not the department's research. Works since 2022-01-01.
| Name | Research topics | h (lifetime) | Works | 1st | Last | Median FWCI |
|---|---|---|---|---|---|---|
| Steven Tringali, DO, FACP | Gastrointestinal motility and disorders; Alcohol Consumption and Health Effects | 7 | 2 | 0 | 2 | 1.01 |
30 trainees are counted above but never listed by name.
About University of California, San Franciscoinstitution-wide internal medicine research
Internal Medicine publications from University of California, San Francisco and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
Works per year · * 2026 so far
Internal Medicine research topics at University of California, San Francisco
Papers in the window; each links to the list on OpenAlex.
- HIV/AIDS Research and Interventions 912
- Tuberculosis Research and Epidemiology 392
- Cancer Immunotherapy and Biomarkers 333
- SARS-CoV-2 and COVID-19 Research 298
- CAR-T cell therapy research 250
- Hepatocellular Carcinoma Treatment and Prognosis 243
- Prostate Cancer Diagnosis and Treatment 238
- Multiple Myeloma Research and Treatments 224
Most cited at University of California, San Francisco since 2024
All internal medicine papers there on OpenAlex
- Non–Small Cell Lung Cancer, Version 4.2024Gregory J. Riely et al. · Journal of the National Comprehensive Cancer Network · 2024 · PubMed · cited 897
- 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid CancerMatthew David Ringel et al. · Thyroid · 2025 · PubMed · cited 835
- 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillationStylianos E. Tzeis et al. · EP Europace · 2024 · PubMed · cited 692
- GliomaMichael Weller et al. · Nature Reviews Disease Primers · 2024 · PubMed · cited 650
- Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023Patrick Barry Mark et al. · The Lancet · 2025 · PubMed · cited 587
- Embracing cancer complexity: Hallmarks of systemic diseaseCharles Swanton et al. · Cell · 2024 · PubMed · cited 555
- The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Lisa M Force et al. · The Lancet · 2025 · PubMed · cited 498
- Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknownsAdeera Levin et al. · Kidney International · 2024 · PubMed · cited 452
- Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in OncologyAl B. Benson et al. · Journal of the National Comprehensive Cancer Network · 2024 · PubMed · cited 406
- Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinomaB. Sangro et al. · Annals of Oncology · 2024 · PubMed · cited 372